ArticleJournal of cancer research and clinical oncology2023

Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study.

Pınar Gursoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.